- 1 hour 20 minutes196 - PCE at 4.1%, GLP-1s for Kids, and OpenAI's Custom Chip — Health:Further Weekly
Vic and Marcus discuss rising inflation, the AI-driven data center boom, and growing concerns about the long-term economic impact of artificial intelligence. They examine major healthcare venture funding rounds, the resurgence of biotech investment, Medicare policy changes, PBM scrutiny, rising healthcare spending driven by GLP-1 drugs, rural hospital transformation, chemotherapy drug shortages, new cancer treatments, and the growing use of Wegovy in children. The episode also covers Bitcoin's sharp decline, venture capital consolidation, and the future of healthcare innovation.
Story Lineup
1 — In This Economy
1:59 - Story 1: PCE Hits 4.1% — The Iran War, the AI Build-Out, and a Fed Caught in the Middle [WSJ]
7:13 - Story 2: AI Infrastructure Is Inflation's New Structural Driver [WSJ]
16:17 - Story 3: AI Bubble Fears Trigger Nasdaq Rout; KOSPI Crashes 10% Overnight [Axios]
18:02 - Story 4: Scott Bessent: Hamilton Inspires Trump Economic Statecraft [WSJ]
2 — VC Deal Review
20:33 - Story 1: Menlo Ventures Closes $3B Fund — Biggest Ever — on the Back of Its Anthropic Bet [TechCrunch]
30:21 - Story 2: Cadence Closes $100M Series C at $1.23B Valuation for AI-Powered Chronic Care [MedCity News]
31:33 - Story 3: Ollin Biosciences Hauls In $330M Series B to Challenge Roche's Vabysmo in Wet AMD [Fierce Biotech]
3 — Policy
32:34 - Story 1: U.S. Health Spending Hits $5.7 Trillion in 2025 — GLP-1 Costs Are a Primary Culprit [Healthcare Dive]
34:43 - Story 2: 31 House Democrats Demand Transparency on CMS's AI Prior-Auth Pilot in Medicare [Healthcare Dive]
4 — Health Payors
38:35 - Story 1: Florida Opens Antitrust Probe Into CVS/Caremark as State-Level PBM Crackdown Accelerates [Healthcare Dive]
43:07 - Story 2: Abarca Health and LucyRx Merge to Build a Scaled Independent PBM Alternative [MedCity News]
44:33 - Story 3: Medicare Advantage at an Inflection: Reset or Retreat? [MedCity News]
5 — Health Systems
50:11 - Story 1: Cancer Chemo Shortages Force Hospitals to Consider Rationing [Becker's]
52:33 - Story 2: Eli Lilly Halts 340B Discounts for Non-Compliant Hospitals, Triggering Legal Battle [MedCity News]
55:39 - Story 3: States Are Using the $50B Rural Health Fund to Shrink Hospitals, Not Transform Care [Healthcare Dive]
6 — Pharma & Novel Therapies
57:38 - Story 1: FDA Approves Two New Drugs to Replace Chemo as First-Line Treatment for Triple-Negative Breast Cancer [WSJ]
59:23 - Story 2: Pfizer's First Major ADC From the $43B Seagen Acquisition Fails Phase 3 [Fierce Biotech]
59:47 - Story 3: AbbVie Pays $10.9B for Apogee to Challenge Dupixent in Eczema [Fierce Biotech]
7 — About Health & Us / The Clinician's Voice
1:00:39 - Story 1: Wegovy for Elementary Schoolers: Pediatricians Turn to GLP-1s as Childhood Obesity Rates Climb [WSJ]
8 — Web3
1:03:47 - Story 1: Bitcoin Hits Multi-Year Low of $58K as BTC and ETH Each Post 20%+ Monthly Losses [CoinDesk]
9 — The AI Tracker
1:06:18 - Story 1: Anthropic Accuses Alibaba of Running a 'Brazen' Campaign to Illicitly Access Claude [WSJ]
1:10:30 - Story 2 : https://www.lennysnewsletter.com/p/glm-52-why-im-replacing-opus-in-claude
1:12:32 - Story 3: OpenAI Unveils 'Jalapeño' — Its First Custom AI Inference Chip Built With Broadcom [WSJ]
1:13:05 - Story 4: X - Satya Nadella - "Frontier without an ecosystem is not stable." [X]
27 June 2026, 4:45 pm - 1 hour 20 minutes195 - Warsh's Fed, the Hormuz Deal, Anthropic's Export Ban, and the Retatrutide Black Market! Ft. Ash Shehata
Marcus welcomes Ash Shehata, former KPMG executive and current Impact Advisors leader, as guest host for a wide-ranging discussion on healthcare, technology, finance, and policy. They examine the Federal Reserve’s evolving approach under Kevin Warsh, the economic implications of reopening the Strait of Hormuz, and SpaceX’s historic IPO alongside its reported Cursor acquisition. The conversation also covers the resurgence of biotech and pharmaceutical M&A, FDA flexibility around gene therapies, rural hospital transformation funding, information blocking enforcement, Medicare Advantage contract disputes, PBM transparency battles, smart hospital rooms, longevity medicine, GLP-1 coverage expansion for seniors, digital assets, tokenized stocks, and the growing role of AI across healthcare and society.
Story Lineup
1 — In This Economy
2:34 - Story 1: Warsh's Fed Ditches Forward Guidance — Markets Brace for Hikes [NYT]
- New Fed Chair Kevin Warsh holds rates but abandons forward guidance at his first FOMC presser, sending rate-hike odds higher and rattling markets — a fundamental shift in central bank posture.
- Tension / discussion: Is Warsh's opacity a feature or a bug? Does removing guidance restore Fed credibility or introduce dangerous ambiguity for markets and borrowers?
- also: Axios
- also: WSJ
6:22 - Story 2: U.S.-Iran Deal Reopens Hormuz, Sends Oil Prices Tumbling [NYT]
- Strait of Hormuz reopens under a U.S.-Iran MOU signed ahead of schedule, driving oil prices lower, gas below $4 nationally, and stocks higher — the biggest macro relief valve in months.
- Tension / discussion: How durable is this deal? A fragile MOU with Iran may give markets false comfort while the underlying geopolitical fault lines remain very much alive.
- also: Axios
- also: Axios
11: 07 - Story 3: SpaceX Acquires AI Coding Agent Cursor for $60 Billion [WSJ]
- SpaceX deploys post-IPO capital in a $60B all-stock acquisition of Cursor, extending Musk's empire into enterprise AI tooling and setting a new benchmark for AI startup valuations.
- Tension / discussion: Does a $60B price tag for a coding agent represent genuine enterprise value or peak AI deal froth? And what does it mean that a rocket company is now a software conglomerate?
- also: Strictly VC
2 — VC Deal Review
14:52 - Story 1: Biopharma M&A Is Back: PwC Reports Strongest Deal Quarter Since 2020 [Fierce Biotech]
- PwC data shows life sciences deal values exceeded $65B in Q1 2026, the strongest quarter in six years — a macro signal that the biopharma financing cycle has turned.
- Tension / discussion: Is this a genuine ecosystem recovery or a buyer's market where big pharma is snapping up distressed assets at favorable prices while smaller biotechs remain starved for capital?
17:58 - Story 2: Kardigan Prices $400M Upsized IPO to Fund Cardiovascular Drug Push [Endpoints]
- Cardiovascular biotech Kardigan prices above expectations in a upsized $400M IPO, the latest evidence that the biotech IPO window is open for the right therapeutic areas.
- Tension / discussion: Cardiovascular drugs have a historically brutal Phase 3 attrition rate — does the IPO enthusiasm reflect genuine science confidence or investor FOMO in a hot market?
FYI
- InStride Raises $30M Series C for Pediatric Mental Health [MedCity News]
- Altaris Acquires AI Drug Dev Platform Simulations Plus for $375M [Fierce Biotech]
- Vedana Therapeutics Emerges With $46M for Next-Gen Migraine Prevention [Fierce Biotech]
3 — Policy
20:01 - Story 1: FDA Reverses Course on uniQure Huntington's Gene Therapy — A Signal of New Regulatory Flexibility [MedCity News]
- FDA greenlights uniQure's Huntington's gene therapy for accelerated approval filing after reversing a prior requirement for an additional trial — a bellwether for how the agency will treat the broader rare disease pipeline.
- Tension / discussion: Is this welcome regulatory modernization for patients with no other options, or does loosening approval standards for gene therapies create a safety accountability gap that will haunt the field?
- also: STAT News
- also: Fierce Biotech
23:35 - Story 2: Rural Hospitals Told to 'Hang On' as Medicare Opt-Outs Accelerate and Closure Funds Lag [Becker's]
- Rural hospital leaders are skeptical the $50B HR 1 transformation fund arrives before closures hit, while a parallel JAMA analysis shows rural physicians are opting out of Medicare faster than anyone is tracking.
- Tension / discussion: Is the Rural Health Transformation Program a genuine lifeline or a political promise that arrives too late for the hospitals and patients that need it most?
- also: Becker's
31:28 - Story 3: Trump HHS Launches Active Information-Blocking Enforcement Under 21st Century Cures Act [Becker's Hospital Review]
- After years of soft implementation, HHS is now actively enforcing information-blocking rules — a compliance wake-up call for health systems, EHR vendors, and health IT companies.
- Tension / discussion: Will enforcement pressure actually unlock data interope...
20 June 2026, 4:57 pm - 1 hour 20 minutes194 - Inflation Rises, SpaceX Demand Surges, and Apple’s AI Strategy Takes Shape
Vic and Marcus discuss rising inflation tied to escalating conflict in Iran and the broader economic implications for energy markets, review major venture capital and healthcare startup funding activity including surgical AI company Uncovr, examine developments in AI adoption and productivity across healthcare, analyze the competitive landscape between Apple and leading AI labs, explore IPO activity ranging from SpaceX demand to healthcare and pharmaceutical offerings, and close with a discussion on robotics, automation, and the impact of humanoid robots on future labor markets.
Links
Story 1: Economy
5:16 - Inflation Jumps as Iran War Intensifies Price Squeeze NYT
9:16 - SpaceX IPO Draws at Least $5 Billion Order From BlackRock
Story 2: VC rundown
15:32 - Surgical AI Startup Uncovr Emerges from Stealth with $7M Seed Funding HIT
16:55 - Stepful raises $55M for healthcare training platform Mobi Health
Story 3: Price transparency
17:40 - Kennedy & Oz Discuss Price transparency on X
Story 4: CMS Top 5 Priorities
22:39 - The 5 Areas Where Dr. Oz Says CMS Can Make Healthcare More Affordable MedCity
Story 5: Drug prices inside EMRs
26:41 - BCBS of Massachusetts partners for lower-cost drug alternatives Healthcare Finance
Story 6: GSK Oncology
28:21 - GSK to Buy Nuvalent for $10.6 Billion in Oncology Push WSJ
Story 7: GLP-1 Pills
28:40 - Novo Nordisk Weight-Loss Pill Prescriptions Hit Three Million Since Launch WSJ
Story 8: Pharma IPO in Canada
30:01 - Apotex Shares Rally as Trading Begins Following Pricing of C$1.3 Billion IPO WSJ
Story 9: Wearable Showdown
31:33 - The Wearable Showdown: Oura Ring 5 vs. Fitbit Air vs. Whoop MG vs. Apple Watch WSJ
Story 10: Agent Payments
34:41 - Coinbase Launches Tool That Lets AI Agents Trade Crypto and Make Payments for Users Decrypt
Story 11: Abridge growth
Story 12: Claude Fable5
40:08 - Anthropic Releases New ‘Mythos-Class’ Model to General Public With Guardrails WSJ
41:16 - bWe've Never Seen an AI Like This (Claude Fable 5) YouTube
Story 13: Price War Coming?
1:05:55 - OpenAI Considers Drastic Price Cuts, Anticipating War for Users With Anthropic WSJ
Story 14: Apple Developer Conf
1:07:37 - Apple Unveiled the New Siri AI. Here Are the Key Takeaways. WSJ
Story 15: Apple Developer Conf
1:12:47 - Driverless Trucks Are Here—and They’re Delivering Bags of Doritos WSJ
13 June 2026, 4:05 pm - 1 hour 3 minutes193 - UnitedHealthcare Medicaid Lawsuit, Hospital AI Expansion, and the New Longevity Boom
Vic and Marcus discuss signs of stress in the private credit market, including redemption pressure at Blackstone, major healthcare and AI funding rounds, and the growing interest of technology investors in longevity startups. They examine legal and regulatory developments involving generic drug marketing, Massachusetts' lawsuit against UnitedHealthcare over alleged Medicaid fraud, and California's action related to the 23andMe data breach. The conversation also covers health system adoption of artificial intelligence through partnerships with General Catalyst, new healthcare AI investments, the evolving IPO market, and growing debate over AI regulation and the role of companies such as Anthropic, Google, and OpenAI.
LinksStory 1: Economy
2:41 - U.S. Job Openings Increased While Hiring Fell in April WSJ
3:17 - U.S. Jobless Claims Rose Last Week WSJ
3:27 - Kevin Warsh Wants the Fed to Think About Inflation Differently WSJ
Story 2: Private Credit - Blackstone
5:44 - Blackstone Investors Ask to Pull $4.4 Billion From Private-Credit Fund WSJ
Story 3: VC rundown
7:14 - Coinbase Founder’s Longevity Startup Triples in Value WSJ
8:15 - Adaptive Innovations Raises $50M in Series A Funding FINSMES
9:37 - Advanced NanoTherapies raises $31M for drug-coated balloon tech Drug Delivery
10:52 - Novellia raises $18M for patient-controlled health data platform MobiHealth
12:55 - Ilant Health Secures $15M to Expand Value-Based Precision Obesity Management HIT
Story 4: SCOTUS
13:45 - It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin Fierce Healthcare
Story 5: MA sues UHG
16:06 - Massachusetts sues UnitedHealthcare for alleged Medicaid fraud Healthcare Dive
16:58 - California attorney general sues over 23andMe data breach Healthcare Dive
Story 6: Ardent new CEO
18:41 - New Ardent Health CEO inherits growth ambitions Healthcare Dive
Story 7: Ascension
21:56 - Ascension closes its $3.9B AmSurg purchase following FTC's all-clear Fierce Healthcare
Story 8: WellSpan
Story 9: New Brain Tumor Treatment
25:33 - Radiation Device Placed in Brain Cuts Tumor Recurrence, Boosts Survival WSJ
Story 10: Lilly 340B
27:53 - Eli Lilly issues data sharing ultimatum to 340B hospitals Healthcare Dive
Story 11: Autism Fraud?
30:53 - The Autism-Therapy Business Is Booming—and So Is the Billing Abuse WSJ
Story 12: Crypto Winter
39:06 - The Crypto Winter Turns Colder as Bitcoin Extends Its Slide WSJ
39:21 - Strategy shares fall after selling $2.5 million in bitcoin, its first sale since 2022 CNBC
Story 13: Tokenized Bank Deposits
42:34 - JPMorgan, Citi and Big Banks Plan New Tokenized Deposit System to Answer Crypto WSJ
Story 14: Mayo Teams with Microsoft
43:44 - Mayo’s latest AI bet: A frontier model with Microsoft Healthcare Dive
Story 15: AI Regulation
45:23 - Trump Signs AI Executive Order to Increase Government Oversight WSJ
Story 16: IPOs
53:50 - Anthropic Files to Go Public in Blockbuster Year for IPOs WSJ
53:59 - Google Seeks $80 Billion for AI Buildout; Berkshire Will Buy $10 Billion Stake WSJ
54:16 - SpaceX Sets Price for the World’s Largest I.P.O. NYT
Story 17: PCs for AI Agents
55:35 - Nvidia Introduces First PCs Designed for AI Agents WSJ
Story 18: Anthropic Reg Capture
6 June 2026, 4:04 pm - 1 hour 53 minutes192 - GLP-1 Frailty Concerns, AI's Impact on Jobs, and Amazon's $6 Billion AI Deal
Vic and guest host Emily Evans discuss declining consumer sentiment, challenges in the labor market, and the growing impact of AI on jobs and small businesses. They examine FDA food regulation and the debate around "generally regarded as safe" ingredients, Medicaid policy changes and fraud enforcement efforts under CMS, the expansion of AI from large enterprises to Main Street businesses, concerns that GLP-1 weight loss drugs may contribute to muscle loss and frailty, and major developments in the AI infrastructure race, including Amazon's multibillion-dollar chip deal.
Links
Story 1: Economy
00:41 - U.S. Consumer Sentiment Worsened in May WSJ
1: 39 - This Summer’s Teen Job Market Is the Toughest in Decades WSJ
4:05 - Phoenix Built an Empire of Cubicle Jobs. AI Is Coming to Tear It Down. WSJ
7:32 - The App for Trump Accounts Will Launch Thursday. Here’s What to Know. WSJ
Story 2: VC rundown
11:04 - Commure raises $70M, boosting post-money valuation to $7B Mobi Health
13:08 - Benefitbay raises $18m Series A to scale ICHRA platform FinTech
18:50 - Nourish raises $100M, plans to expand care model with physicians Fierce Healthcare
23:07 - Private Loans to Venture-Backed Startups Surge Despite AI Disruption Concerns WSJ
Story 3: Political Hard-Ball Impacts Medicaid
25:50 - Trump Nemesis Sen. Bill Cassidy Defeated in GOP Primary WSJ
26:04 - Paxton Wins Texas Republican Primary After Trump Endorsement WSJ
29:58 - Trump administration proposes crackdown on Medicaid state-directed payments Healthcare Dive
Story 4: New CMS Health Plan Flexibility
45:08 - New Final Rule Pushes Marketplace Enrollees Toward Lower-Quality, More Expensive Coverage CBPPStory 5: HHS Fraud Crackdown
58:19 - HHS launches AI-backed health fraud crackdown Healthcare Dive
Story 6: CVS and the end of PBMs
1:06:01 - CVS sues to challenge Tennessee's new PBM law Fierce Healthcare
1:08:17 - Bipartisan lawmakers reintroduce bill barring PBMs from owning pharmacies Fierce Healthcare
1:10:27 - Brokers increasingly recommending ICHRA to employers Fierce Healthcare
1:12:36 - Hospitals sue CVS Health alleging it redirected $250M in 340B funds Healthcare Finance
Story 7: Training more Docs (finally)
1:15:26 - 5 physician residency programs launching or expanding in 2026 Beckers
Story 8: Quorum as a Nonprofit
1:16:09 - Quorum Health transitioning to nonprofit for financial pickup Fierce Healthcare
Story 9: Big Health Brands moving quickly
1:20:53 - Amazon One Medical launches GLP-1 program integrated with primary care Fierce Healthcare
Story 10: Lilly’s moves
1:30:22 - One-and-Done Heart Disease Prevention? Scientists Show It May Be Possible. NYT
1:32:00 - Lilly Agrees to Buy Trio of Vaccine Developers WSJ
Story 11: GLP1 Side Effects
1:39:13 - Is the Weight-Loss Drug Revolution Causing a Frailty Epidemic? WSJ
Story 12: Ebola Watch
1:41:49 - Doctors, Hospitals Struggle to Keep Up With Ebola’s Spread WSJ
Story 13: New Chip Entries Grow
1:44:25 - Huawei Says It Has Workaround to Match Leading Chips WSJ
1:45:42 - Amazon Strikes $6 Billion Deal With Snowflake for Agentic Computing Chips WSJ
Story 14: New Chip Entries Grow
30 May 2026, 7:01 pm - 29 minutes 33 seconds191 - FT. Chris Boone: Oracle, AI, and the Future of Healthcare, Real World Evidence, Precision Medicine, and Workforce Change
Vic and Marcus sit down with Chris Boone, Group Vice President of Research Services at Oracle Health and Life Sciences, live from the Jumpstart Health Summit. The conversation explores Oracle’s growing role in healthcare following its Cerner acquisition, the future of real world evidence in drug discovery, how artificial intelligence is reshaping clinical research and healthcare organizations, and the opportunities and challenges surrounding AI adoption, regulation, workforce transformation, and precision medicine. They also discuss predictive healthcare, autonomous agents, the evolution of healthcare leadership, and what a world free of disease could realistically look like.
23 May 2026, 3:44 pm - 1 hour 15 minutes190 - Marty Makary Resigns, AI Bubble Concerns Grow, and Healthcare Keeps California Afloat
Vic and Marcus discuss rising inflation driven by energy costs and the impact on consumers, travel, and wage growth. They examine newly confirmed Fed Chair Kevin Warsh and debate whether AI investment and market enthusiasm are creating an economic bubble. The episode covers healthcare job growth becoming a key driver of California’s economy, major healthcare venture funding activity, and the resignation of FDA Commissioner Marty Makary and what it could signal about the future of regulation. Additional topics include declining overdose deaths, changes to PBMs after Optum Rx moves to a fee-based model, Hims & Hers struggling after the GLP-1 shift, General Catalyst’s healthcare transformation efforts, US and China negotiations, and broader conversations around healthcare, policy, and technology.
Links
Story 1: CPI
1:44 - Inflation Soared to 3.8% in April, Driven by Gasoline Prices WSJ
3:24 - Prices at the Pump Are Wiping Out Wage Gains WSJ
Story 2: New fed Chair
4:51 - Kevin Warsh Is Confirmed as Fed Chair in 54–45 Senate Vote WSJ
Story 3: Jobs
11:42 - U.S. Adds 115,000 Jobs in April With Solid Hiring Across Sectors WSJ
13:43 - Cisco to Shed Jobs for All-In AI Push WSJ
14:21 - Forget Tech and Hollywood. California Is Powered by Healthcare Jobs. WSJ
Story 4: VC rundown
20:04 - Google-backed Isomorphic Labs raises $2.1B for AI drug discovery platform Mobi Health
Story 5: Policy rundown
21:08 - FDA Commissioner Marty Makary, Under Pressure From Trump, Resigns WSJ
33:11 - Vance to States: Address Fraud or Lose Federal Medicaid Funding WSJ
43:24 - U.S. Drug Overdose Deaths Fall for Third Straight Year WSJ
44:17 - Trump Was Flattering, Xi Was Resolute. The Difference Spoke Volumes. NYT
Story 6: Optum Moving Away from Traditional PBM Model
49:39 - Optum Rx replaces traditional PBM model with a fee-based structure Healthcare Finance
Story 6: UC reaches deal with Union
51:38 - University of California, union reach late-night deal to avert system-wide strike Fierce Healthcare
Story 7: Digital Health Earnings
52:33 - Hims & Hers posts $92M loss in Q1 as it shifts to branded GLP-1 medications Fierce Healthcare
Story 8: GC Hosts Kennedy in Ohio
55:47 - General Cataylst & HatCo host Kennedy in Akron LI
Story 9: Far Reaching Negative Impact of Hearing Loss
58:17 - Walking Slower? Why Your Ears, Not Your Knees, Might Be the Problem WSJ
Story 10: Clarity Act
1:00:27 - Clarity Act clears U.S. Senate committee, on its way to a final test in Congress CoinDesk
Story 11: SpaceX & Google
1:06:06 - SpaceX and Google Are in Talks to Launch Data Centers in Orbit WSJ
Story 12: Googlebooks
1:08:45 - Google’s Android-powered laptops are called Googlebooks, and they’re coming this year Ars Technica
Story 13: Robots You Wear
1:11:37 - Human + Robot Limitless
16 May 2026, 5:51 pm - 1 hour 30 minutes189 - Hantavirus Fears Rise as Global Officials Respond | AI Layoffs Accelerate | Google Expands in Healthcare
Vic and Marcus discuss the latest signals from the labor market and growing concerns around AI-driven layoffs, including workforce cuts at Coinbase, PayPal, and other major companies. They examine how AI is reshaping healthcare operations, payer strategies, and pharmaceutical distribution, with conversations covering IBM and OpenAI’s work with Elevance, Hims & Hers launching AI lab interpretation tools, Google’s push into consumer health, and Roche acquiring PathAI. The episode also covers RFK Jr.’s push to reduce antidepressant use, the SEC proposal to eliminate quarterly reporting, CVS and Oscar Health earnings, UPMC acquiring CommonSpirit’s Trinity Health assets, renewed momentum at Pfizer and Novo Nordisk, and the rapid convergence of AI agents, crypto payments, and cloud infrastructure through AWS, Coinbase, and Stripe.
Links
Story 1: Jobs market
1:52 - March Labor Market Was Stable, if Sluggish WSJ
3:08 - Job Market Starts to Show Glimmers of Good News WSJ
Story 2: Private Credit watch
4:02 - HSBC Takes $400 Million Hit From Private-Credit Alleged Fraud WSJ
Story 3: AI Org changes
5:20 - AI Is Forcing CEOs to Make a Stark Choice: Lay Off Workers or Make Them Do More WSJ
5:40 - Coinbase layoff X
10:46 - PayPal to Cut 20% of Staff Amid Turnaround Push WSJ
12:12 - IBM CEO Says AI Triggers Need for New Operating Models WSJ
Story 4: VC rundown
13:37 - Startup Enabling Aging at Home Raises $6M, Gains New MA and Medicaid Partnerships MedCity
15:32 - Enzo Health raises $20M to expand AI home health platform Mobi Health
17:09 - XCaliber Health scores $6.5M for workflow platform Mobi Health
19:06 - Village: $9.5 Million Raised For Specialty Pediatrics AI Platform Pulse 2.0
Story 5: Antidepressants
22:02 - RFK Jr. Wants to Wean Some Americans Off Antidepressants WSJ
Story 6: End of Quarterly requirements?
25:45 - SEC Proposes to Eliminate Quarterly Reporting Requirement for Public Companies WSJ
Story 7: Elevance
30:39 - California hospitals sue to block Elevance out-of-network penalty Modern Healthcare
Story 8: Payor earnings
33:22 - CVS’s Results Add to Positive Momentum for Health-Insurance Industry WSJ
35:48 - Oscar Health's profit hits $679M, membership rises in Q1 Fierce Healthcare
Story 9: UPMC
40:02 - UPMC to acquire CommonSpirit’s Trinity Health Modern Healthcare
Story 10: Health provider earnings
42:45 - Ardent touts outpatient volume, margin growth during hectic Q1 Fierce Healthcare
43:54 - Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions Fierce Healthcare
Story 11: Pharma
44:50 - Pfizer Posts Better-Than-Expected Revenue, Profit WSJ
46:30 - Novo Nordisk Shares Jump on Strong Demand for Wegovy Pill WSJ
48:46 - Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion WSJ
Story 12: Pharma
Hantavirus Case in Switzerland Spurs Race to Trace Contacts WSJ
57:06 - Global Health Officials Race to Track Hantavirus but Predict ‘Limited’ Outbreak NYT
Story 13: AWS agent payments
59:36 - AWS taps Coinbase and Stripe to power USDC payments for AI agents The Block
Story 14: Hims AI
1:02:57 - Hims & Hers debuts its first AI care agent to interpret biomarker lab results Fierce Healthcare
Story 15: Google Fitbit
1:04:44 - A comprehensive view of your health: Google Blog
1:06:27 - Google unveils Whoop-like screenless Fitbit Air TechCrunch
Story 16: Anth...
9 May 2026, 7:00 am - 1 hour 7 minutes188 - Chinese Robot Beats Human, AI Beats Doctors, UAE Exits OPEC
Vic and Marcus cover Jerome Powell remaining on the Federal Reserve board and concerns around Fed independence, global instability including the UAE exiting OPEC and weakening international institutions, and hyperscaler dominance with strong earnings from Google, Amazon, and Microsoft driven by AI and cloud growth; they discuss venture funding trends including brain-computer interfaces and clinical AI models, FDA adoption of AI to accelerate clinical trials, and policy shifts including the withdrawal of Casey Means’ nomination and Cigna exiting ACA markets; the episode also explores payer performance, Humana’s partnership with Mark Cuban’s Cost Plus Drugs, pharma consolidation led by Eli Lilly, and rising acquisition costs in biotech; they examine societal impacts of reduced human interaction due to technology, crypto instability and DeFi bailouts, and major AI developments including OpenAI’s slowing growth, legal challenges, China blocking Meta’s acquisition of Manus, and the accelerating gap between AI systems and human expertise in medicine
Links
Story 1: Fed Meeting
3:04 - Powell to Remain on Fed Board, Citing Legal Pressure From Trump WSJ
Story 2: OPEC
5:45 - U.A.E.’s OPEC Exit Deals Major Blow to Cartel Amid Middle East Oil Squeeze WSJ
Story 3: Cloud providers
9:35 - Google Profit Jumps 81% as Cloud Business Booms WSJ
12:49 - Amazon Posts Double-Digit Growth Anchored by Booming Web Services WSJ
13:15 - Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist WSJ
Story 4: VC
15:54 - Axoft Raises $55M Series A to Advance Brain-Computer Interface Technology CityBiz
19:22 - Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model Fierce Healthcare
Story 5: FDA Looking to RWD
24:30 - FDA Turns to AI to Speed Up Clinical Trials WSJ
Story 6: Surgeon General
26:23 - Trump Withdraws Nomination of Casey Means for Surgeon General NYT
Story 7: Payors
29:54 - Cigna to exit ACA market, pursue strategic alternatives for eviCore unit Fierce Healthcare
34:24 - Humana teams with Mark Cuban's Cost-Plus Drug Company Healthcare Finance
Story 8: UHS
36:13 - Universal Health Services' Q1 2026 earnings growth dampened by volume hits Fierce Healthcare
Story 9: Pharma
37:36 - Eli Lilly to Buy Ajax Therapeutics for Up to $2.3 Billion WSJ
39:06 - Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal WSJ
40:47 - There’s a Revolution in Cancer. But Can Big Pharma Afford It? WSJ
Story 10:
43:20 - We’re All Talking to Each Other Less Than We Did a Decade Ago WSJ
Story 11: Robinhood
50:00 - Robinhood Profit Rises on Boost From Prediction Markets, Gold Subscriptions WSJ
Story 12: Aave
51:48 - Crypto Rushes to Bail Out Decentralized Lender Targeted by Hackers WSJ
Story 13: AI Diagnosing Patients
56:23 - In real-world test, an AI model did better than ER doctors at diagnosing patients NPR
N/A - Performance of a large language model on the reasoning tasks of a physician Science
Story 14: OpenAI
58: 11 -OpenAI Misses Key Revenue, User Targets in High-Stakes Sprint Toward IPO WSJ
1:00:20 - OpenAI Sued by Seven Families Over Mass Shooting Suspect’s ChatGPT Use WSJ
1:01:35 - Elon Musk Testifies He Was a ‘Fool’ to Fund OpenAI WSJ
Story 15: China
1:02:41 - China Bans Meta’s Acquisition of Manus on National Security Grounds WSJ
2 May 2026, 7:00 am - 57 minutes 59 seconds187 - Trump Legalizes Medical Marijuana, China Beat Nvidia Without Chips, Gene Therapy Restores Hearing
Vic and Marcus recap insights from the Health Evolution Summit, focusing on high-value networking versus weak conference content, then break down major economic and policy developments including Kevin Warsh’s expected appointment as Fed Chair, the end of the investigation into Jerome Powell, and shifts in Fed governance. They cover venture activity across AI healthcare, biotech resurgence, and crowded revenue cycle startups, alongside new accelerators backed by Anne Wojcicki. Policy wins include FDA gene therapy breakthroughs, marijuana reclassification, and faster CMS coverage pathways. The episode dives into payer performance with improved MLR trends, ongoing health system struggles, and biotech deal momentum led by Eli Lilly. They explore AI’s growing role in healthcare, including dementia care and OpenAI launching clinical tools, while also unpacking infrastructure pressures from data center demand, chip innovation, and inference growth. The episode closes with geopolitical tensions in AI, highlighting Nvidia vs China debates, the rise of DeepSeek, and rapid advancements in robotics performance.
Links
Story 1: Kevin Warsh - Fed
5:12 - Warsh Pledges Independence at Fed Hearing WSJ
6:11 - DOJ drops investigation into Fed’s Powell Roll Call
Story 2: VC
11:59 - Courier Health scores $50M to scale CRM technology Mobi Heath
13:19 - Esther and Anne Wojcicki back new healthcare accelerator, fund TechCrunch
Story 3: 1st Gene Therapy
14:54 - FDA Approves First-Ever Gene Therapy to Restore Hearing WSJ
Story 4: Marijuana reclassified
16:51 - Trump Administration Reclassifies Marijuana as Less Dangerous Drug WSJ
Story 5: RAPID
18:44 - CMS and FDA announce RAPID Medicare coverage for breakthrough medical devices Healthcae Finance
Story 6: Payor Financial Reports
20:43 - UnitedHealth Shows Signs of Turnaround With Strong Quarterly Results WSJ
21:58 - Molina controls costs in Q1 but future Medicaid spending in doubt Healthcare Dive
22:33 - Elevance perks up in 2026 though Medicare Advantage payout could ding profits Healthcare Dive
Story 7: CHS Reports Loss
23:11 - Flagging first-quarter volumes dragged CHS’ earnings Healthcare Dive
Story 8: Pharma Rundown
23:58 - Boston Scientific Net Grows Sharply WSJ
24:56 - Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer NYT
25:41 - After Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy? Fierce Healthcare
Story 9: Pharma Rundown
26:58 - New York Sues Coinbase, Gemini Over Crypto Exchanges’ Prediction Markets WSJ
Story 10: AI for Dementia
32:03 - For Dementia Patients, AI Can Be a Good, Non-Judgmental Listener WSJ
Story 11: OpenAI
Story 12: Datacenters and Infrence
39:17 - Oracle’s Deluge of AI Debt Pushes Wall Street to the Limit WSJ
43:38 - Intel Shares Jump 20% as AI Agents Drive Big Growth WSJ
44:22 - Google Introduces Specialized Chip for New Wave of AI Computing WSJ
47:06 - Dwarkesh Podcast w/ Jensen - YouTube
51:54 - Deepseek on X - X
Story 13: Robot Marathon
56:05 - Chinese Robot Beats Human Best Time in Half-Marathon, After a Stumble WSJ
25 April 2026, 7:00 am - 1 hour 1 minute186 - How AI Agents Are Quietly Rewriting Jobs, Healthcare, and the Economy
Vic and Marcus break down a surge in AI development, starting with Vic’s hands-on experience building autonomous agents and what it reveals about the future of work, productivity, and identity. They discuss the growing gap between economic growth and job creation, the psychological impact of AI on workers, and parallels to past industry disruptions. The episode covers venture activity in healthcare, including AI-native operating systems, fertility innovation, and value-based care startups, alongside policy updates like digital health reimbursement models and system-wide labor tensions. They examine the expanding role of GLP-1 drugs beyond weight loss, major pharma momentum, and the increasing convergence of AI and healthcare. The conversation shifts to infrastructure challenges with data centers, global competition, and regulatory friction, before diving into rapid AI advancements across OpenAI, Anthropic, Google, and robotics, ending with a broader reflection on purpose, identity, and adapting in an accelerating world.
Links
Story 1: Economic Rundown
12:32 -The Economy Is Growing, Jobs Aren’t. Why That Might Be OK. WSJ
18:50 - Process to Refund Tariffs to Begin Next Week WSJ
19:22 - U.S. Economy Remains Resilient in Face of Iran War, Banks Say WSJ
Story 2: VC
N/A - Helical raises $10M seed for virtual pharma AI lab Axios
21:05 - Ultralight Raises $9.3M Seed Round SaaS News
22:32 - Joyful Health Raises $17M in Series A Funding for FinTech FinSms
Story 3: FDA Peptides
23:01 - FDA moves toward easing restrictions on certain peptides Healthcare Dive
Story 4: ACCESS
23:56 - CMS accepts more than 150 providers, digital health firms for ACCESS model Healthcare Dive
Story 5: BSW Exits ACA & Medicaid
25:38 - Baylor Scott & White Health Plan to depart individual market, Medicaid this year Fierce Healthcare
Story 6: Walmart Better Care
Story 7: UC Health Strike
28:19 - UC Health workers plan open-ended, system-wide strike for May 14 Fierce Healthcare
Story 8: J & J
30:28 - J&J’s First-Quarter Sales Grow on Cancer-Drug Strength WSJ
Story 9: Lilly Acq
Story 10: ?
32:34 - (The New York Times) Online and in Doctors Offices. People are Finding that GLP-1s
Story 11: Web 3
35:28 - Elon Musk’s X Money Stands to Disrupt Payments and Pressure PayPal
38:18 - Charles Schwab Begins Rollout of Spot Bitcoin, Ethereal trading Platform
Story 12: Anthropic
39:38 - Anthropic Adds Novartis CEO to Board WSJ
40:42 - Anthropic Releases Claude Opus 4.7 to Remind Everyone How Great Mythos Is Gizmodo
Story 13: Open AI
43:14 - OpenAI unveils GPT‑5.4‑Cyber, an AI model for defensive cybersecurity 9to5Mac
43:40 - OpenAI’s big Codex update is a direct shot at Anthropic’s Claude Code The Verge
OpenAI unveils GPT‑5.4‑Cyber, an AI model for defensive cybersecurity - 9to5MacVergeStory: 14 Data Center Fights
45:29 - Elon Musk’s xAI Sued by NAACP Over Memphis Data Center WSJ
47:49 - Maine Lawmakers Pass Ban on Large Data Centers WSJ
48:38 - AI Is Using So Much Energy That Computing Firepower Is Running Out WSJ
Story 15: Gemini
51:02 -Google launches a Gemini AI app on Mac The Verge
51:59 - DeepMind launches Gemini Robotics-ER 1.6 to meet precise physical AI demands SilconAngle
18 April 2026, 7:00 am - More Episodes? Get the App